Drug Shortage Report for SCOPOLAMINE HYDROBROMIDE INJECTION

Last updated on 2020-02-20 History
Report ID 103719
Drug Identification Number 02242811
Brand name SCOPOLAMINE HYDROBROMIDE INJECTION
Common or Proper name Scopolamine Hydrobromide Injection
Company Name OMEGA LABORATORIES LIMITED
Market Status MARKETED
Active Ingredient(s) SCOPOLAMINE HYDROBROMIDE
Strength(s) 0.6MG
Dosage form(s) LIQUID
Route of administration INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Packaging size 10 x 1mL vial /fiole
ATC code N05CM
ATC description HYPNOTICS AND SEDATIVES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-01-17
Estimated end date 2020-01-31
Actual end date 2020-02-14
Shortage status Resolved
Updated date 2020-02-20
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 11177 HAMON
MONTREAL, QUEBEC
CANADA H3M 3E4
Company contact information info@omegalaboratory.com - 1-800-363-0584

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2020-02-20 French Compare
v3 2020-02-20 English Compare
v2 2020-01-20 French Compare
v1 2020-01-20 English Compare

Showing 1 to 4 of 4